2024 annual financial data
Tarsus Pharmaceuticals 2024 Operating margin
Direct answer
Operating margin was -65.9%.
Operating income was -120,569,000 USD and net income was -115,554,000 USD.
Operating cash flow was -83,027,000 USD.
Get free Tarsus Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 182,953,000 USD
- Operating income
- -120,569,000 USD
- Net income
- -115,554,000 USD
- Operating cash flow
- -83,027,000 USD